期刊文献+

Combination treatment with comprehensive cryoablation and immunotherapy in metastatic hepatocellular cancer 被引量:18

Combination treatment with comprehensive cryoablation and immunotherapy in metastatic hepatocellular cancer
暂未订购
导出
摘要 AIM: To retrospectively assess the effect of comprehensive cryosurgery (ablation of intraand extra-hepatic tumors) plus dendritic cell-cytokine-induced killer cell immunotherapy in metastatic hepatocellular cancer. METHODS: We divided 45 patients into cryo-immunotherapy (21 patients), cryotherapy (n = 12), immunotherapy (n = 5) and untreated (n = 7) groups. Overall survival (OS) after diagnosis of metastatic hepatocellular cancer was assessed after an 8-year follow-up. RESULTS: Median OS was higher following cryo-immu-notherapy (32 mo) or cryotherapy (17.5 mo; P < 0.05) than in the untreated group (3 mo) and was higher in the cryo-immunotherapy group than in the cryotherapy group (P < 0.05). In the cryo-immunotherapy group, median OS was higher after multiple treatments (36.5 mo) than after a single treatment (21 mo; P < 0.05). CONCLUSION: Cryotherapy and, especially, cryoimmunotherapy significantly increased OS in metastatic hepatocellular cancer patients. Multiple cryo-immunotherapy was associated with a better prognosis than single cryo-immunotherapy. AIM: To retrospectively assess the effect of comprehensive cryosurgery (ablation of intra- and extra-hepatic tumors) plus dendritic cell-cytokine-induced killer cell immunotherapy in metastatic hepatocellular cancer. METHODS: We divided 45 patients into cryo-immunotherapy (21 patients), cryotherapy (n = 12), immunotherapy (n = 5) and untreated (n = 7) groups. Overall survival (OS) after diagnosis of metastatic hepatocellular cancer was assessed after an 8-year follow-up. RESULTS: Median OS was higher following cryo-immunotherapy (32 mo) or cryotherapy (17.5 mo; P < 0.05) than in the untreated group (3 mo) and was higher in the cryo-immunotherapy group than in the cryotherapy group (P < 0.05). In the cryo-immunotherapy group, median OS was higher after multiple treatments (36.5 mo) than after a single treatment (21 mo; P < 0.05). CONCLUSION: Cryotherapy and, especially, cryo-immunotherapy significantly increased OS in metastatic hepatocellular cancer patients. Multiple cryo-immunotherapy was associated with a better prognosis than single cryo-immunotherapy.
出处 《World Journal of Gastroenterology》 SCIE CAS 2013年第22期3473-3480,共8页 世界胃肠病学杂志(英文版)
关键词 CRYOABLATION DENDRITIC cell-cytokine-induced KILLER CELL IMMUNOTHERAPY METASTATIC hepatocellular cancer Survival time Cryoablation Dendritic cell-cytokine-induced killer cell Immunotherapy Metastatic hepatocellular cancer Survival time
  • 相关文献

参考文献13

  • 1Ji-Bing Chen,Jia-Liang Li,Li-Hua He,Wei-Qun Liu,Fei Yao,Jian-Ying Zeng,Yi Zhang,Ke-Qiang Xu,Li-Zhi Niu,Jian-Sheng Zuo,Ke-Cheng Xu.Radical treatment of stage Ⅳ pancreatic cancer by the combination of cryosurgery and iodine-125 seed implantation[J].World Journal of Gastroenterology,2012,18(47):7056-7062. 被引量:10
  • 2Tadashi Shimizu,Yusuke Sakuhara,Daisuke Abo,Yu Hasegawa,Yoshihisa Kodama,Hideho Endo,Hiroki Shirato,Kazuo Miyasaka.Outcome of MR-guided percutaneous cryoablation for hepatocellular carcinoma[J].Journal of Hepato - Biliary - Pancreatic Surgery.2009(6)
  • 3Georg A. Pistorius M.D.,Christof Alexander M.D.,Carl-Martin Krisch M.D.,Gernot Feifel M.D.,Martin K. Schilling M.D.,Michael D. Menger M.D.Local Platelet Trapping as the Cause of Thrombocytopenia after Hepatic Cryotherapy[J].World Journal of Surgery.2005(5)
  • 4Said A,Wells J.Management of hepatocellular carcinoma[].Minerva Medica.2009
  • 5Hodgson,HJF.Primary hepatocellular carcinoma[].British Journal of Hospital Medicine.1983
  • 6Dusheiko GM,Hobbs KE,Dick R,et al.Treatment of small hepatocellular carcinomas[].The Lancet.1992
  • 7Burroughs A,Hochhauser D,Meyer T.Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum[].The Lancet Oncology.2004
  • 8Llovet JM,Ricci S,Mazzaferro V,Hilgard P,Gane E,Blanc JF,de Oliveira AC,Santoro A,Raoul JL,Forner A,Schwartz M,Porta C,Zeuzem S,Bolondi L,Greten TF,Galle PR,Seitz JF,Borbath I,Haussinger D,Giannaris T,Shan M,Moscovici M,Voliotis D,Bruix J.Sorafenib in advanced hepatocellular carcinoma[].The New England Journal of Medicine.2008
  • 9DAVIS CR.Interventional radiological treatment of hepatocellular carcinoma[].Cancer Control.2010
  • 10Fuss M,Salter BJ,Herman TS,Thomas CR,Jr.External beam radiation therapy for hepatocellular carcinoma: potential of intensity-modulated and image-guided radiation therapy[].Gastroenterology.2004

二级参考文献3

共引文献9

同被引文献107

引证文献18

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部